Dopamine-sensitive adenylate cyclase in mammalian brain: a possible site of action of antipsychotic drugs.

No abstract is available for this paper.

• Publication year

  1974

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  1974-04-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1073/PNAS.71.4.1113PMID 4151517PMCID PMC388173
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN.

  2009cited by this paper
• Neural regulation of growth hormone secretion.

  1978cited by this paper
• An anatomy of schizophrenia?

  1973cited by this paper
• Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

  1973cited by this paper
• Effect of clozapine on the turnover of dopamine in the corpus striatum and in the limbic system

  1973cited by this paper
• Dopaminergic neurons: effect of antipsychotic drugs and amphetamine on single cell activity.

  1973cited by this paper
• Dopamine turnover in the corpus striatum and the limbic system after treatment with neuroleptic and anti‐acetylcholine drugs

  1972cited by this paper
• Dopamine-sensitive adenylate cyclase in caudate nucleus of rat brain, and its similarity to the "dopamine receptor".

  1972cited by this paper
• Catecholamines in the brain as mediators of amphetamine psychosis.

  1972cited by this paper
• Clozapine, a novel major tranquilizer. Clinical experiences and pharmacotherapeutic hypotheses.

  1972cited by this paper
• Stereotaxic mapping of the monoamine pathways in the rat brain.

  1971cited by this paper
• Neurochemical pathology and pharmacology of brain dopamine and acetylcholine: rational basis for the current drug treatment of Parkinsonism.

  1971cited by this paper
• Clinical use of psychotherapeutic drugs.

  1970cited by this paper
• Effect of apomorphine and pimozide on synthesis and turnover of labelled catecholamines in mouse brain

  1970cited by this paper
• Effect of chlorpromazine on accumulation and disappearance of catecholamines formed from tyrosine-C14 in brain.

  1968cited by this paper
• Extrapyramidal side effects and clinical response to the phenothiazines.

  1961cited by this paper

• Laboratory epigenetic models of schizophrenia

  2021cites this paper
• cAMP-regulated phosphoproteins DARPP-32, ARPP16/19, and RCS modulate striatal signal transduction through protein kinases and phosphatases.

  2021cites this paper
• Embryonic and postnatal development of mouse olfactory tubercle.

  2019cites this paper
• Antipsychotic prescribing patterns on admission to and discharge from a tertiary care program for treatment-resistant psychosis at Riverview Hospital

  2017cites this paper
• Biochemistry and the Search for Therapeutic Agents

  2015cites this paper
• Altered Subcellular Distribution of the 75‐kDa DISC1 Isoform, cAMP Accumulation, and Decreased Neuronal Migration in Schizophrenia and Bipolar Disorder: Implications for Neurodevelopment

  2015cites this paper
• Functional Studies of Dopamine-D2S Receptor Signaling through the RASA3 Pathway

  2014cites this paper
• Chemotherapy in psychiatry

  2013cites this paper
• History of the Discovery of the Antipsychotic Dopamine D2 Receptor: A Basis for the Dopamine Hypothesis of Schizophrenia

  2013cites this paper
• Dopamine receptor signaling and current and future antipsychotic drugs.

  2012cites this paper
• Parkinson’s Disease

  2012influential citation
• D1/D5 Dopamine Agonists as Pharmacotherapy for Schizophrenia

  2012cites this paper
• The History of Neuroscience in AutobiographyVolume 7

  2011cites this paper
• Schizophrenia: Nature of the Disease Process and its Biological Correlates

  2011cites this paper
• Beyond the Dopamine Receptor: Regulation and Roles of Serine/Threonine Protein Phosphatases

  2011cites this paper
• What dopamine does in the brain

  2011cites this paper
• Third generation antipsychotic drugs: partial agonism or receptor functional selectivity?

  2010cites this paper
• Dopamine D1 receptors, regulation of gene expression in the brain, and neurodegeneration.

  2010cites this paper
• Artificial neural network (ANN) based modelling for D1 like and D2 like dopamine receptor affinity and selectivity.

  2010cites this paper
• Differential effect of phenothiazines on MRP1 and P-glycoprotein activity.

  2009cites this paper
• The pharmacology of a new potent, long acting neuroleptic, piflutixol.

  2009cites this paper
• Functional Selectivity at Dopamine Receptors

  2009cites this paper
• Effect of lipophilicity of substituted benzamides on the dopaminergic effects in vivo and in vitro.

  2009cites this paper
• Leslie L. Iversen

  2009cites this paper
• Adenylate cyclase in rat synaptosomal plasma membranes and caudate nucleus homogenate: effects of dopamine, E prostaglandins, guanyl-5'-yl-imidodiphosphate and morphine.

  2009cites this paper
• Structural basis for ligand-binding and activation of D1-like dopamine receptors

  2008cites this paper
• INVESTIGATION OF THE ELECTROPHYSIOLOGICAL PROPERTIES OF THE MAJOR CELL TYPES IN THE RAT OLFACTORY TUBERCLE

  2008cites this paper
• A Review of the Discovery, Pharmacological Characterization, and Behavioral Effects of the Dopamine D2‐Like Receptor Antagonist Eticlopride

  2008cites this paper
• Dopamine receptor pharmacology.

  2007cites this paper
• Neurotransmitter-mediated inhibition of post-mortem human brain adenylyl cyclase

  2005cites this paper
• Chapter II Signal transduction of dopamine receptors

  2005cites this paper
• Brain dopamine receptors: 20 Years of progress

  2004cites this paper
• Central levels of noradrenaline, 3-methoxy-4-hydroxyphenylethyleneglycol and cyclic AMP in the rat after activation of Locus coeruleus neurons: Influence of single and repeated neuroleptic treatment

  2004cites this paper
• Differential alterations in striatal dopamine receptor sensitivity induced by repeated administration of clinically equivalent doses of haloperidol, sulpiride or clozapine in rats

  2004cites this paper
• Interactions of a neuroleptic drug (fluphenazine) with catecholamines in hippocampus

  2004cites this paper
• On the mechanism of the decrease in cerebellar cyclic GMP content elicited by opiate receptor agonists

  2004cites this paper
• Opiate receptors and beyond: 30 years of neural signaling research.

  2004cites this paper
• Dopamine and mania: Behavioral and biochemical effects of the dopamine receptor blocker pimozide

  2004cites this paper
• Responses to apomorphine, amphetamine, and neuroleptics in schizophrenic subjects

  2004cites this paper
• Anti-dopaminergic and anti-muscarinic effects of dibenzodiazepines

  2004cites this paper
• Dopaminomimetic action of diphenylhydantoin in rat striatum: Effect on homovanillic acid and cyclic AMP levels

  2004cites this paper
• Electrophysiologic interactions of antipsychotic drugs with central noradrenergic pathways

  2004cites this paper
• Dopamine- and apomorphine-sensitive adenylate cyclase in homogenates of rabbit retina

  2004cites this paper
• Decreased striatal dopamine D1 receptor-stimulated adenylyl cyclase activity in human methamphetamine users.

  2003cites this paper
• Structural Analysis of the Mammalian D2, D3 and D4 Dopamine Receptors

  2003cites this paper
• Dopamine in the CNS I

  2002cites this paper
• Brain Research, 107(1976)303-315 303 _'3 ElsevierScienlilic Publishing C'ompany,Amsterdam Printed in The Netherlands TOPOGRAPHICAL DISTRIBUTION OF DOPAMINERGIC INNERVATION AND OF DOPAMINERGIC RECEPTORS IN THE RAT STRIATUM. II. DISTRIBUTION AND CHARACTERISTICS OF DOPAMINE ADENY- LATE CYCLASE -- INTER

  2002cites this paper
• Signal Transduction by Dopamine D1 Receptors

  2002cites this paper
• QRAR models for central nervous system drugs using biopartitioning micellar chromatography.

  2002cites this paper
• Dopamine D1-stimulated adenylyl cyclase activity in cerebral cortex of autopsied human brain.

  2001cites this paper
• Parkinson's disease and D1 dopamine receptors.

  2001cites this paper
• Synaptic transmission: a story of successive successes

  2001cites this paper
• D1 dopamine receptors.

  2001cites this paper
• Parkinson's disease and D 1 dopamine receptors

  2001cites this paper
• Modulation of Cellular Signaling Pathways by Antipsychotic Drugs

  2000cites this paper
• RENAL DOPAMINERGIC MECHANISMS AND HYPERTENSION: A CHRONOLOGY OF ADVANCES

  2000cites this paper
• CEREBROSPINAL FLUID CYTOLOGY IN SCHIZOPHRENIA

  2000cites this paper
• Development of predictive retention-activity relationship models of antipsychotic drugs by micellar liquid chromatography.

  1999cites this paper
• Monoaminergic synapses and schizophrenia: 45 years of neuroleptics

  1998cites this paper
• The History of the Psychopharmacology of Schizophrenia

  1997cites this paper
• Psychotropic and neurotropic activity

  1997cites this paper
• Molecular Drug Design and Dopamine Receptors

  1997cites this paper
• Long-term neuroleptic treatments counteract dopamine D2 agonist inhibition of adenylate cyclase but do not affect pertussis toxin ADP-ribosylation in the rat brain.

  1996cites this paper
• Classification Schemes for Antipsychotic Drugs

  1996cites this paper
• Receptor and cellular mechanisms of antipsychotic drugs

  1996cites this paper
• The D-1 dopamine receptor: past, present and future an idiosyncratic review.

  1995cites this paper
• Inhibition of Dopamine Agonist‐Induced Phosphoinositide Hydrolysis by Concomitant Stimulation of Cyclic AMP Formation in Brain Slices

  1994cites this paper
• Evidence that systemically administered dopamine antagonists activate dopamine neuron firing primarily by blockade of somatodendritic autoreceptors.

  1994cites this paper
• Dopamine receptors: molecular biology, biochemistry and behavioural aspects.

  1994cites this paper
• Molecular and Cell Biology of Neuropsychiatric Diseases

  1994cites this paper
• The neurochemistry of schizophrenia.

  1994cites this paper
• [Localization of two neurotropic molecules in cultured glial cells by ion microscopy].

  1992cites this paper
• Biochemistry of schizophrenia

  1992cites this paper
• Mesocorticolimbic dopaminergic network: functional and regulatory roles.

  1991cites this paper
• Effect of opioid agonists selective for three subclasses of opioid receptors and one sigma receptor agonist on dopamine stimulated adenylate cyclase in rat caudate nucleus.

  1991cites this paper
• Characterization and regional distribution of adenylyl cyclase activity from human brain.

  1991cites this paper
• Mechanisms of action of atypical antipsychotic drugs. Implications for novel therapeutic strategies for schizophrenia.

  1991cites this paper
• Dopamine receptors expressed in the Xenopus oocytes injected with bovine striatal mRNA.

  1990cites this paper
• The effects of clozapine on rat mast cells are different from those of benzodiazepines.

  1990cites this paper
• Die Bedeutung der D 1 - und D 2 -Dopaminrezeptor-Blockade für die antipsychotische Wirkung von Neuroleptika. Eine PET-Studie an schizophrenen Patienten

  1990cites this paper
• The opioid system in neurologic and psychiatric disorders and in their experimental models.

  1990cites this paper
• Effects of spiperone, raclopride, SCH 23390 and clozapine on apomorphine inhibition of sensorimotor gating of the startle response in the rat.

  1990cites this paper
• Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics

  1990cites this paper
• A mechanism additional to cyclic AMP accumulation for vasoactive intestinal peptide-induced prolactin release.

  1990cites this paper
• Dopaminergic Neurons: Basic Aspects

  1989cites this paper
• Effects of chlorpromazine in the nucleus reticularis lateralis on the cat cerebellar potentials.

  1989cites this paper
• Dopamine D1 receptors labelled with [3H]SCH23390 in rabbit cerebral cortex and neostriatum Equilibrium binding, kinetics and selectivity

  1989cites this paper
• Receptor mechanisms in antipsychotic drug action: focus on sigma receptors.

  1989cites this paper
• [The neurochemistry of schizophrenia].

  1989cites this paper
• Antitumor and toxic effects of combination chemotherapy with bleomycin and a phenothiazine anticalmodulin agent.

  1988cites this paper
• Actions of dopamine antagonists on stimulated striatal and limbic dopamine release: an in vivo voltammetric study

  1988cites this paper
• The Mechanisms of Action of Antipsychotics and Antidepressant Drugs

  1988cites this paper
• Chlorpromazine-sensitive developmental processes in the sea urchin, Lytechinus pictus—II. Effects of neuroactive agents on the susceptibility of the gastrulation process to chlorpromazine

  1988cites this paper
• D1 dopamine receptors in human putamen, frontal cortex and calf retina: differences in guanine nucleotide regulation of agonist binding and adenylate cyclase stimulation.

  1988cites this paper
• Anatomical And Pharmacological Comparisons Between Dopamine D-1 And D-2 Receptors In Mammalian Cns

  1988cites this paper
• Dopamine receptors and the dopamine hypothesis of schizophrenia

  1987cites this paper
• Mechanisms of CNS injury in behavioral dysfunction.

  1987cites this paper
• Pharmacological properties of fluphenazine-mustard, an irreversible calmodulin antagonist.

  1987cites this paper
• Physical treatments.

  1987cites this paper
• Review: D1 dopamine receptor—the search for a function: A critical evaluation of the D1/D2 dopamine receptor classification and its functional implications

  1987cites this paper